Tag: GCP compliance

GCP-Compliant Monitoring Strategies: Balancing On-Site and Remote Approaches

Posted on By digi

GCP-Compliant Monitoring Strategies: Balancing On-Site and Remote Approaches In clinical research, ensuring compliance with Good Clinical Practice (GCP) is paramount for the successful execution of clinical trials. It not only guarantees the safety of trial participants but also ensures the integrity and credibility of the data. This document serves as a comprehensive guide for clinical…

Read More “GCP-Compliant Monitoring Strategies: Balancing On-Site and Remote Approaches” »

Monitoring per GCP (On-site/Remote)

Risk-Based Monitoring Under ICH E6(R3): From Theory to Execution

Posted on By digi

Risk-Based Monitoring Under ICH E6(R3): From Theory to Execution Risk-Based Monitoring Under ICH E6(R3): From Theory to Execution In the fast-evolving landscape of clinical trials, particularly within oncology clinical research, the emphasis on maintaining high-quality standards of data and patient safety is paramount. ICH E6(R3) introduces a shift toward Risk-Based Monitoring (RBM) principles that enhance…

Read More “Risk-Based Monitoring Under ICH E6(R3): From Theory to Execution” »

Monitoring per GCP (On-site/Remote)

Root Cause Analysis in Clinical Trials: Going Beyond Surface Symptoms

Posted on By digi

Root Cause Analysis in Clinical Trials: Going Beyond Surface Symptoms Root Cause Analysis in Clinical Trials: Going Beyond Surface Symptoms Root cause analysis (RCA) is a critical process in maintaining the quality and integrity of clinical trials. By identifying the underlying causes of problems, clinical operations, regulatory affairs, and medical affairs professionals can address issues…

Read More “Root Cause Analysis in Clinical Trials: Going Beyond Surface Symptoms” »

Root Cause Analysis (5 Whys, Fishbone)

Transitioning Participants to Standard of Care or New Studies

Posted on By digi

Transitioning Participants to Standard of Care or New Studies In the realm of clinical research, transitioning participants from clinical trials to standard of care or enrolling them in new studies is a critical process that demands meticulous planning and execution. This article aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a…

Read More “Transitioning Participants to Standard of Care or New Studies” »

Close-Out Visits & Archiving

Decommissioning Study Systems and Vendor Contracts at Close-Out

Posted on By digi

Decommissioning Study Systems and Vendor Contracts at Close-Out Effective close-out procedures are a critical phase in the lifecycle of clinical trials. The process of decommissioning study systems and managing vendor contracts at close-out ensures compliance, safeguards data, and prepares the trial for regulatory inspection. This tutorial serves as a step-by-step guide for clinical operations, regulatory…

Read More “Decommissioning Study Systems and Vendor Contracts at Close-Out” »

Close-Out Visits & Archiving

Integrating Source Data Requirements Into Protocol and SAP

Posted on By digi

Integrating Source Data Requirements Into Protocol and SAP Integrating Source Data Requirements Into Protocol and SAP In the realm of applied clinical trials, the integration of source data requirements into the study protocol and statistical analysis plan (SAP) constitutes a critical aspect of compliance with regulatory standards. As clinical trials evolve, regulatory bodies such as…

Read More “Integrating Source Data Requirements Into Protocol and SAP” »

Source Data & ALCOA++

Source Data Archiving and Long-Term Integrity Under GCP

Posted on By digi

Source Data Archiving and Long-Term Integrity Under GCP This comprehensive tutorial provides clinical operations, regulatory affairs, and medical affairs professionals with step-by-step guidance on the best practices surrounding source data archiving and ensuring long-term integrity under Good Clinical Practice (GCP) regulations. Special attention will be paid to the role of data safety monitoring boards (DSMB)…

Read More “Source Data Archiving and Long-Term Integrity Under GCP” »

Source Data & ALCOA++

KPIs for Deviation and Incident Management Performance in Clinical QMS

Posted on By digi

KPIs for Deviation and Incident Management Performance in Clinical QMS KPIs for Deviation and Incident Management Performance in Clinical Quality Management Systems Introduction to Key Performance Indicators (KPIs) in Clinical Trials In the realm of clinical research, the effectiveness of deviation and incident management is critical for ensuring the integrity of data and the safety…

Read More “KPIs for Deviation and Incident Management Performance in Clinical QMS” »

Deviation/Incident Management

Close-Out Documentation That Satisfies Auditors and Inspectors

Posted on By digi

Close-Out Documentation That Satisfies Auditors and Inspectors Close-Out Documentation That Satisfies Auditors and Inspectors In clinical trials, the close-out phase concludes the research and is critical for ensuring compliance with regulations set by governing bodies such as the FDA, EMA, and MHRA. Proper close-out documentation serves as proof of compliance and is essential for any…

Read More “Close-Out Documentation That Satisfies Auditors and Inspectors” »

Close-Out Visits & Archiving

Managing Biobank and Sample Storage Commitments at Study End

Posted on By digi

Managing Biobank and Sample Storage Commitments at Study End In the complex landscape of clinical research, managing biobank and sample storage commitments at the study end can be a daunting task for professionals in clinical operations, regulatory affairs, and medical affairs. Effective management is crucial not only for regulatory compliance but also for ensuring that…

Read More “Managing Biobank and Sample Storage Commitments at Study End” »

Close-Out Visits & Archiving